Analyst Ratings for Gilead Sciences (GILD)

Overall Rating: BUY Rating Trend: Down

Avg. $ Target: $64.47 (+15.7%)

Date	Firm	Type	Rating (Past)	PT (Past)	Start $	End $	% Chg.	Details
2/19/2013	Credit Suisse	Upgrade	Outperform (Neutral)	N/A (N/A)	41.60	55.74	33.99%	Details
2/5/2013	Atlantic Equities	Downgrade	Neutral (Overweight)	N/A (N/A)	39.59	55.74	40.79%	Details
12/13/2012	Goldman Sachs	New Coverage	Neutral (N/A)	81.00 (N/A)	76.23	55.74	-26.88%	Details
11/9/2012	Guggenheim	New Coverage	Buy (N/A)	87.00 (N/A)	64.85	55.74	-14.05%	Details
10/8/2012	Lazard Capital	Upgrade	Buy (Neutral)	N/A (N/A)	69.43	55.74	-19.72%	Details
10/1/2012	Bernstein	Upgrade	Outperform (Market Perform)	N/A (N/A)	66.33	55.74	-15.97%	Details
8/2/2012	Barclays » Updated 8/28/2012	Upgrade	Overweight (Equalweight)	65.00 (N/A)	53.63	55.74	3.93%	Details
7/17/2012	Maxim Group » Updated 4/22/2013	New Coverage	Buy (N/A)	97.00 (48.00)	51.94	55.74	7.32%	Details
3/15/2012	Stifel Nicolaus	New Coverage	Buy (N/A)	57.00 (N/A)	46.66	55.74	19.46%	Details
2/10/2012	Morgan Stanley	New Coverage	Overweight (N/A)	65.00 (N/A)	53.73	55.74	3.74%	Details
11/23/2011	Argus	Downgrade	Hold (N/A)	N/A (N/A)	38.76	55.74	43.81%	Details
11/22/2011	Summer Street	Downgrade	Neutral (N/A)	N/A (N/A)	36.26	55.74	53.72%	Details
11/22/2011	BMO Capital	Upgrade	Outperform (N/A)	49.00 (N/A)	36.26	55.74	53.72%	Details
11/21/2011	Citi » Updated 3/18/2013	Upgrade	Buy (N/A)	60.00 (46.00)	35.08	55.74	58.89%	Details
10/19/2011	Standpoint Research	Downgrade	Hold (N/A)	N/A (N/A)	40.76	55.74	36.75%	Details

Like GILD Ratings? Also take a look at IDIX, BMY, VRTX, MRK